ANNA KANISHCHEVA: Open Payments
NPI 1588985964 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 4 payments from 4 companies in 2025. Trend: 2023 $933 · 2024 $135 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 1 | $121 |
| Amgen Inc. | 1 | $108 |
Products named: FRUZAQLA, LIBTAYO, KYPROLIS.
Industry payments across NY — which companies pay providers there.
